Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Versamet VMET crushes estimates as EPS shatters forecasts revenue surges 189 YoY yet shares slip 126 How Option OPCH is positioning for the next five years Volatility Increases 20260503 What Tectonic Therapeutic TECX management focus reveals about priorities On the Radar 20260508 How SPX Technologies SPXC management quality drives results Falls 20260505 Charles Schwab Opens Crypto Doors to Retail Investors in Major Digital Asset Expansion XAI XFLT Stalls at 1919 Breakout or Breakdown 20260515 Fox Corporation FOX Slides 137 as Selling Pressure Mounts 20260514 AllegroMicro ALGM Reports Strong Q1 2026 Revenue NA EPS Beats US Seeks to Expand American AI Footprint in Asia Following TrumpXi Meeting Trump Pressures Bank of America and JPMorgan Over Alleged Bias Against Conservatives DeepSeek AI Model from China Gains Silicon Valley Acclaim Despite Chip Constraints Fed Rate Hike Expectations Surge Futures Market Prices in Increase as Early as December OMC Stocks Rally as Brent Crude Dips and Fuel Prices Rise for Fourth Time AIRelated Layoffs May Not Guarantee Stock Market Gains Data Suggests Esperion Therapeutics Holds Steady Near Support Testing Key Resistance Zone Kaixin Holdings KXIN Surges Nearly 5 Whats Driving the Momentum Smith Nephew SNATS SNN Slips 075 Technical Support Tested Near 3053 Twelve Seas Investment Company III TWLV Holds Steady Near Trust Value as Trading Activity Remains Subdued Super League Enterprise Inc SLE Slides 696 Amid Market Volatility Key Support Tested New York Times Pips Puzzle Guide for Friday May 22 Edition JHX Q1 2026 Earnings Earnings Per Share Miss Estimates Stock Gains Slightly LXFR Q1 2026 Earnings Strong EPS Beat Validates Operational Efficiency MOLN Q4 2025 Earnings Narrowed Loss Exceeds Expectations as Pipeline Progress Continues RXO Reports Continued Surge in Truckload Spot Market During Second Quarter REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Awaits Clinical Milestones